Skipping standard axillary lymph node dissection led to very low rates of axillary recurrence in patients with node-positive breast cancer who became node-negative following neoadjuvant chemotherapy, ...

引言2022 年全球乳腺癌的新发病例数接近 230 万例，死亡病例约为 67 万例，在女性肿瘤中的发病率和死亡率均排名第一[1]。根据 2022 年国家癌症中心的最新统计，中国乳腺癌新发病例数 35.72 万例，在女性癌症中仅次于肺癌，占比为 ...

A prognostic miRNA based signature in early-stage HER2-positive breast cancer patients. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This abstract does not include a full text ...

Targeted axillary dissection (TAD) is a relatively new breast cancer procedure. It allows surgical oncologists to specifically locate a lymph node that contained cancer before chemotherapy, remove it ...

MIAMI BEACH -- The surgical dogma favoring axillary dissection in breast cancer continues to give way to more selective data-driven strategies that allow more women to avoid axillary surgery, an ...

Recently, omission of axillary lymph node dissection among patients with early breast cancer has been found to have no detrimental effect on outcomes in most cases, continuing a trend toward less ...

Axillary reverse mapping (ARM) is an innovative surgical technique aimed at accurately delineating the lymphatic drainage of the upper extremity from that of the breast during axillary lymph node ...

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Omission of completion axillary lymph node dissection did not increase recurrence among patients ...

Women with hormone receptor (HR)–positive, human epidermal growth factor receptor 2 (HER2)–negative breast cancer who have one positive sentinel node and no high-risk features can likely be spared ...

Ovarian granulosa cell tumors are a rare type of ovarian cancer that affect the ovaries and fallopian tubes, and can extend further into the pelvis and lymph nodes. Treatment typically follows the ...